Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 25, 2025, titled "Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025".
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has submitted to NSE a press release dated April 25, 2025, containing its audited financial results on both a standalone and consolidated basis. The results cover the fourth quarter as well as the full financial year ending March 31, 2025. This filing is essentially a regulatory notification that the company has published its annual financial results in the form of a press release. Investors will need to refer to the actual press release to see the detailed revenue, profit, and other key financial numbers.
This is a procedural disclosure confirming that the company's audited FY25 results have been released. The actual stock or shareholder impact will depend on the revenue and profit numbers in the detailed results, which are not included in this filing.